Literature DB >> 20176655

Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers.

Ja-Lok Ku1, Young-Kyoung Shin, Duck-Woo Kim, Kyung-Hee Kim, Jin-Sung Choi, Sung-Hye Hong, You-Kyung Jeon, Sung-Hee Kim, Hong-Sun Kim, Jae-Hyun Park, Il-Jin Kim, Jae-Gahb Park.   

Abstract

Thirteen human colorectal cancer (CRC) cell lines were established from 10 primary tumors and 3 metastatic tumors obtained from 13 Korean patients. Characteristics of the cell lines including morphology in vivo and in vitro; mutations of the K-ras, p53, APC and MMR genes and microsatellite instability (MSI) status in vitro were determined. Expression of drug-sensitivity genes including MDR1, MXR, MRP1 and COX2 was also analyzed. The cell lines were unique as judged by DNA fingerprinting using 16 short tandem repeats. Eleven of the cell lines grew as adherent populations and the remaining two as floating aggregates. None of the cell lines were contaminated with Mycoplasma or bacteria. All cell lines showed high viability with relatively long doubling times. Six cell lines contained mutations at K-ras. Seven cell lines displayed p53 gene missense, nonsense and frameshift mutations. MSI was found in three cell lines and two cell lines with an MSI-high phenotype-possessed hMLH1 mutations. Nine cell lines had an APC mutation. MRP1 was highly expressed in all cell lines, and high expression of MDR1, MXR and COX2 evident in eight, six and six cell lines, respectively. Embryonal stem cell markers (MELK, SOX4 and OCT4) were expressed in most of cell lines. The cancer stem cell biomarkers CD133, CD44 and Lgr5 were expressed in 12, 13 and 13 cell lines, respectively. The presently well-characterized CRC cell lines should be useful in investigations of the biological characteristics of CRC, particularly for investigations related to gene alterations associated with CRC and biology of cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176655     DOI: 10.1093/carcin/bgq043

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  24 in total

Review 1.  The two faces of FBW7 in cancer drug resistance.

Authors:  Zhiwei Wang; Hidefumi Fukushima; Daming Gao; Hiroyuki Inuzuka; Lixin Wan; Alan W Lau; Pengda Liu; Wenyi Wei
Journal:  Bioessays       Date:  2011-08-30       Impact factor: 4.345

2.  Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.

Authors:  Hong-Ying Zhen; Qi-Hua He; Yong-Zhan Zhen; Shu-Ling Wang; Yi-Nan Liu; Wei-Hua Wu; Xiao-Yan Zhang; Ai-Li Lu; Li Shen
Journal:  Invest New Drugs       Date:  2010-07-02       Impact factor: 3.850

3.  Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase.

Authors:  Christopher N Johnson; Christophe Adelinet; Valerio Berdini; Lijs Beke; Pascal Bonnet; Dirk Brehmer; Frederick Calo; Joseph E Coyle; Phillip J Day; Martyn Frederickson; Eddy J E Freyne; Ron A H J Gilissen; Christopher C F Hamlett; Steven Howard; Lieven Meerpoel; Laurence Mevellec; Rachel McMenamin; Elisabeth Pasquier; Sahil Patel; David C Rees; Joannes T M Linders
Journal:  ACS Med Chem Lett       Date:  2014-05-23       Impact factor: 4.345

4.  Fragment-based discovery of type I inhibitors of maternal embryonic leucine zipper kinase.

Authors:  Christopher N Johnson; Valerio Berdini; Lijs Beke; Pascal Bonnet; Dirk Brehmer; Joseph E Coyle; Phillip J Day; Martyn Frederickson; Eddy J E Freyne; Ron A H J Gilissen; Christopher C F Hamlett; Steven Howard; Lieven Meerpoel; Rachel McMenamin; Sahil Patel; David C Rees; Andrew Sharff; François Sommen; Tongfei Wu; Joannes T M Linders
Journal:  ACS Med Chem Lett       Date:  2014-05-23       Impact factor: 4.345

5.  Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro.

Authors:  Melanie Arul; April Camilla Roslani; Swee Hung Cheah
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-01-24       Impact factor: 2.416

6.  Genetic variations in stem cell-related genes and colorectal cancer prognosis.

Authors:  Hushan Yang; Falin Qu; Ronald E Myers; Guoqiang Bao; Terry Hyslop; Guang Hu; Fei Fei; Jinliang Xing
Journal:  J Gastrointest Cancer       Date:  2012-12

7.  Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.

Authors:  Feng-Juan Gao; Jie-Yu Chen; Hong-Yan Wu; Jiong Shi; Ming Chen; Xiang-Shan Fan; Qin Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  Comparison of leucine-rich repeat-containing G protein-coupled receptor 5 expression in different cancer and normal cell lines.

Authors:  Reza Alizadeh-Navaei; Alireza Rafiei; Saeid Abedian-Kenari; Hossein Asgarian-Omran; Reza Valadan; Akbar Hedayatizadeh-Omran
Journal:  Biomed Rep       Date:  2016-05-20

9.  A Mouse Model of Targeted Musashi1 Expression in Whole Intestinal Epithelium Suggests Regulatory Roles in Cell Cycle and Stemness.

Authors:  F M Cambuli; B R Correa; A Rezza; S C Burns; M Qiao; P J Uren; E Kress; A Boussouar; P A F Galante; L O F Penalva; M Plateroti
Journal:  Stem Cells       Date:  2015-09-26       Impact factor: 6.277

Review 10.  The emerging roles of Oct4 in tumor-initiating cells.

Authors:  Ying-Jie Wang; Meenhard Herlyn
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-07       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.